New evidence of a causal link between herpes viruses and Alzheimer’s reinvigorates research into the possible role of infections — and their treatment — in the disease
What causes Alzheimer’s disease? The answer could be right under our noses, says leading expert Professor Ruth Itzhaki. Her latest paper presents a lifetime of research evidence that the herpes virus responsible for cold sores can also cause Alzheimer’s – and new data which show antiviral drugs drastically reduce risk of senile dementia in patients with severe herpes infections. The review in Frontiers in Ageing Neuroscience raises the tantalizing prospect of a simple, effective preventive treatment for one of humanity’s costliest disorders.
The HSV1 theory of Alzheimer’s disease
Herpes viruses are the dreaded ‘gift that keeps on giving’. They remain lifelong in our neurons and immune cells, reactivating and resurfacing in characteristic blisters when we’re run down by stress or illness. Most people are infected by Herpes Simplex Virus 1 (HSV1) by the time they reach old age.
But what happens to infected neurons in our brain during this reactivation?
“HSV1 could account for 50% or more of Alzheimer’s disease cases,” says Professor Itzhaki, who has spent over 25 years at the University of Manchester investigating a potential link.
HSV1 is better known as the cause of cold sores. Itzhaki has shown previously that cold sores occur more frequently in carriers of APOE-?4 – a gene variant that confers increased risk of Alzheimer’s.
“Our theory is that in APOE-?4 carriers, reactivation is more frequent or more harmful in HSV1-infected brain cells, which as a result accumulate damage that culminates in development of Alzheimer’s.”
Proving the theory
Few countries collect the population data required to test this theory – for example, to find out whether antiviral treatments reduce dementia risk.
In Taiwan however, researchers have done just that. There, 99.9% of the population is enrolled in a National Health Insurance Research Database, which is being extensively mined for information on microbial infections and disease. In 2017-2018 three studies were published describing Taiwanese data on the development of senile dementia – of which Alzheimer’s is the main cause – and the treatment of patients with marked overt signs of infection with HSV or varicella zoster virus (VZV, the chickenpox virus).
“The striking results include evidence that the risk of senile dementia is much greater in those who are infected with HSV, and that anti-herpes antiviral treatment causes a dramatic decrease in number of those subjects severely affected by HSV1 who later develop dementia.”
Previous findings from Itzhaki’s own research group provide a mechanistic link which supports these epidemiological findings. They found that HSV1 causes protein deposits characteristic of Alzheimer’s: ‘plaques’ between neurons, and ‘tangles’ inside of them.
“Viral DNA is located very specifically within plaques in postmortem brain tissue from Alzheimer’s sufferers. The main proteins of both plaques and tangles accumulate also in HSV1-infected cell cultures – and antiviral drugs can prevent this.”
Towards a cure
“It should be stressed that the results of these Taiwanese studies apply only to severe HSV1 (or VZV) infections, which are rare,” admits Itzhaki. “Ideally, we would study dementia rates amongst people who have suffered mild HSV1 infection, including herpes labialis (cold sores) or mild genital herpes, but these are far less likely to be documented.”
Although further work is needed to confirm and define a causal link between HSV1 infection and Alzheimer’s, Itzhaki is enthusiastic about the treatment prospects.
“Considering that over 150 publications strongly support an HSV1 role in Alzheimer’s, these Taiwan findings greatly justify usage of antiherpes antivirals – which are safe and well-tolerated – to treat Alzheimer’s disease.
“They also incentivize development of an HSV1 vaccine, which would likely be the most effective treatment.”
This echoes the growing use worldwide of human papillomavirus (HPV) vaccination to prevent cervical cancer – another virus-disease link which emerged in a similar process of research.
Learn more:Â Does herpes cause Alzheimer’s?
The Latest on: HSV1 vaccine
[google_news title=”” keyword=”HSV1 vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: HSV1 vaccine
- The vaccine that can prevent cold soreson May 1, 2024 at 5:00 pm
The first vaccine to protect against the herpes virus ... There are five types of herpes virus, but herpes simplex-1 or HSV-1 and herpes simplex-2, HSV-2, are the most common.
- SARS vaccines: where are we?on April 30, 2024 at 5:00 pm
In this review, the current state of vaccine development against human severe acute respiratory syndrome (SARS) coronavirus, focusing on recently published data is assessed. We discuss which ...
- Vaccines Newson April 28, 2024 at 5:00 pm
Mar. 12, 2024 — Researchers have highlighted the importance of continued surveillance of emerging SARS-CoV-2 variants and vaccine performance as the virus continues to ... Mar. 8, 2024 — COVID ...
- RFK Jr.: Interview excerpt of him saying there is ‘no vaccine that is safe and effective’ is ‘misused’on April 27, 2024 at 10:36 am
Independent presidential candidate Robert F. Kennedy Jr. said an interview excerpt of him saying there is “no vaccine that is safe and effective” has been “misused” Friday. “I made that ...
- Is There a Vaccine for H5N1 Influenza?on April 21, 2024 at 5:00 pm
Opens in a new tab or window On the heels of a multi-state outbreak of highly pathogenic avian influenza A (H5N1) in dairy cows, experts told MedPage Today that a trio of H5N1 vaccines for humans ...
- WHO's top scientist sounds alarm about bird flu and need for vaccine developmenton April 19, 2024 at 12:39 pm
World Health Organization’s top scientist said this week the recent bird flu outbreak is of “great concern” to public health, and vaccine development to halt the virus is “not where we ...
- New Vaccine Could Protect Against Any Strain of a Virus With One Shoton April 18, 2024 at 6:43 am
Scientists seem to be close to creating a "one-and-done" vaccine that can protect against any strain of a virus with just one shot. In a press release from the University of California ...
- Every year, tuberculosis kills over a million people. Can a new vaccine turn the tide?on April 14, 2024 at 4:00 am
But beyond those factors, when it comes to preventing illness and death in these regions, physicians, researchers, and public health officials say that the available vaccine and treatments don’t ...
- Global Stockpile of Cholera Vaccine Is Gone as Outbreaks Spreadon April 10, 2024 at 5:00 pm
April 11, 2024 Doses of cholera vaccine are being given to patients as fast as they are produced and the global stockpile has run completely dry, as deadly outbreaks of the disease continue to spread.
via Bing News